Skip to main content
Log in

Sichere Behandlung der akuten Hyperkaliämie

Das 1:4 und andere Prinzipien

Safe treatment of acute hyperkalemia

The 1:4 and other principles

  • Allgemeinanästhesie
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Die akute Hyperkaliämie ist eine gefährliche und sofort zu behandelnde Elektrolytstörung. Durch Veränderungen im Membranpotenzial kann sie zu Herzrhythmusstörungen und Tod führen. Die auftretenden EKG-Veränderungen sind vielfältig und sollten schnell erkannt werden. Die Therapie besteht aus verschiedenen Stufen. Neben einer allfällig notwendigen Membranstabilisierung gilt es, Kalium in den Intrazellulärraum zu verschieben und danach aus dem Körper zu eliminieren. Eine gängige Methode zur Verschiebung des Kaliums in den Intrazellulärraum besteht aus der durchaus komplikationsträchtigen Verabreichung von Insulin-Glucose-Gemischen. Hier kommen im klinischen Alltag vielfältige Rezeptvariationen zur Anwendung, die im Hinblick auf das jeweilige Nutzen-Risiko-Verhältnis nicht immer ideal zu sein scheinen. Ein praxistaugliches und gut memorierbares Insulin-Glucose-Gemisch weist ein Verhältnis von 1 IE Insulin zu 4 g Glucose (1:4) auf. Die therapeutische Elimination aus dem Körper geschieht über eine gesteigerte Diurese oder die Anwendung von Nierenersatzverfahren. Ein besonderes Augenmerkt muss der engmaschigen Kontrolle des Kaliums und des Blutzuckerspiegels zukommen. Nach Überwindung der Akutsituation muss das Augenmerk auf der Therapie der zugrunde liegenden Störung und ggf. auf der Neueinstellung der Dauermedikation des Patienten liegen.

Abstract

Acute hyperkalemia is a dangerous electrolyte disorder, which must be treated immediately. It can lead to cardiac arrhythmia and death due to alterations in cell membrane potentials. The resulting alterations in the electrocardiogram (ECG) are multifarious and need to be rapidly recognized. Treatment consists of various stages. In addition to membrane stabilization, which is always necessary, potassium must be displaced into the intracellular space and then eliminated from the body. A commonly applied method for displacement of potassium into the intracellular space involves the administration of insulin-glucose mixtures, which is associated with many complications. In the clinical routine many prescription variations are applied, which do not always appear to be ideal with respect to the individual risk-benefit ratio. A practically useful and easily memorized insulin-glucose mixture has a relationship of 1IU insulin to 4g glucose. The therapeutic elimination from the body is carried out using an enhanced diuresis or the utilization of renal replacement procedures. Special attention must be paid to the continous monitoring of potassium and blood sugar levels. After overcoming the acute situation, attention must be paid to treatment of the underlying disorder and if necessary to readjustment of the long-term medication of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Ahee P, Crowe AV (2000) The management of hyperkalaemia in the emergency department. J Accid Emerg Med 17:188–191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ahmed J, Weisberg LS (2001) Hyperkalemia in dialysis patients. Semin Dial 14:348–356

    Article  CAS  PubMed  Google Scholar 

  3. Alfonzo A (2014) Treatment of acute hyperkalemia in adults. http://www.renal.org/docs/default-source/default-document-library/hyperkalaemia-guideline---march-2014.pdf (Table 3). Zugegriffen: 5.4.2017

    Google Scholar 

  4. Allon M, Copkney C (1990) Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 38:869–872

    Article  CAS  PubMed  Google Scholar 

  5. Allon M, Dunlay R, Copkney C (1989) Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 110:426–429

    Article  CAS  PubMed  Google Scholar 

  6. Allon M, Shanklin N (1996) Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 28:508–514

    Article  CAS  PubMed  Google Scholar 

  7. Blanie A, Ract C, Leblanc PE et al (2012) The limits of succinylcholine for critically ill patients. Anesth Analg 115:873–879

    Article  CAS  PubMed  Google Scholar 

  8. Chamberlain MJ (1964) Emergency treatment of hyperkalaemia. Lancet 1:464–467

    Article  CAS  PubMed  Google Scholar 

  9. Davey M (2002) Calcium for hyperkalaemia in digoxin toxicity. Emerg Med J 19:183

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Davey M, Caldicott D (2002) Calcium salts in management of hyperkalaemia. Emerg Med J 19:92–93

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Elliott MJ, Ronksley PE, Clase CM et al (2010) Management of patients with acute hyperkalemia. CMAJ 182:1631–1635

    Article  PubMed  PubMed Central  Google Scholar 

  12. Graber M, Subramani K, Corish D et al (1988) Thrombocytosis elevates serum potassium. Am J Kidney Dis 12:116–120

    Article  CAS  PubMed  Google Scholar 

  13. Halperin ML, Kamel KS (1998) Potassium. Lancet 352:135–140

    Article  CAS  PubMed  Google Scholar 

  14. Harel Z, Kamel KS (2016) Optimal dose and method of administration of intravenous insulin in the management of emergency hyperkalemia: a systematic review. PLOS ONE 11:e0154963

    Article  PubMed  PubMed Central  Google Scholar 

  15. Herold G (2012) Innere Medizin. Gerd Herold, Köln

    Google Scholar 

  16. Hollander-Rodriguez JC, Calvert JF Jr. (2006) Hyperkalemia. Am Fam Physician 73:283–290

    PubMed  Google Scholar 

  17. Hundal HS, Marette A, Mitsumoto Y et al (1992) Insulin induces translocation of the alpha 2 and beta 1 subunits of the Na+/K(+)-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267:5040–5043

    CAS  PubMed  Google Scholar 

  18. Kellerman PS, Thornbery JM (2005) Pseudohyperkalemia due to pneumatic tube transport in a leukemic patient. Am J Kidney Dis 46:746–748

    Article  PubMed  Google Scholar 

  19. Kim HJ (1996) Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 72:476–482

    Article  CAS  PubMed  Google Scholar 

  20. Lens XM, Montoliu J, Cases A et al (1989) Treatment of hyperkalaemia in renal failure: salbutamol v. insulin. Nephrol Dial Transplant 4:228–232

    Article  CAS  PubMed  Google Scholar 

  21. Ljutic D, Rumboldt Z (1993) Should glucose be administered before, with, or after insulin, in the management of hyperkalemia? Ren Fail 15:73–76

    Article  CAS  PubMed  Google Scholar 

  22. Mahajan SK, Mangla M, Kishore K (2001) Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients. J Assoc Physicians India 49:1082–1085

    CAS  PubMed  Google Scholar 

  23. Mahoney BA, Smith WA, Lo DS et al (2005) Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. doi:10.1002/14651858.cd003235

    PubMed  Google Scholar 

  24. Mandelberg A, Krupnik Z, Houri S et al (1999) Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? how safe? Chest 115:617–622

    Article  CAS  PubMed  Google Scholar 

  25. Martin TJ, Kang Y, Robertson KM et al (1990) Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function. Anesthesiology 73:62–65

    Article  CAS  PubMed  Google Scholar 

  26. Parham WA, Mehdirad AA, Biermann KM et al (2006) Hyperkalemia revisited. Tex Heart Inst J 33:40–47

    PubMed  PubMed Central  Google Scholar 

  27. Ringer S (1883) A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart. J Physiol (Lond) 4:29–42

    Article  CAS  Google Scholar 

  28. Rossain W, Werner C, Zwißler B (Hrsg) (2012) Die Anästhesiologie. Springer, Heidelberg, S 121

    Google Scholar 

  29. Scherr L, Ogden DA, Mead AW et al (1961) Management of hyperkalemia with a cation-exchange resin. N Engl J Med 264:115–119

    Article  CAS  PubMed  Google Scholar 

  30. Sindhu SK, Hix JK, Fricke W (2011) Pseudohyperkalemia in chronic lymphocytic leukemia: phlebotomy sites and pneumatic tubes. Am J Kidney Dis 57:354–355

    Article  PubMed  Google Scholar 

  31. Sterns RH, Grieff M, Bernstein PL (2016) Treatment of hyperkalemia: something old, something new. Kidney Int 89:546–554

    Article  CAS  PubMed  Google Scholar 

  32. Williams PS, Davenport A, Bone JM (1988) Hypoglycaemia following treatment of hyperkalaemia with insulin and dextrose. Postgrad Med J 64:30–32

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Groene.

Ethics declarations

Interessenkonflikt

P. Groene und G. Hoffmann geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Groene, P., Hoffmann, G. Sichere Behandlung der akuten Hyperkaliämie. Anaesthesist 66, 426–430 (2017). https://doi.org/10.1007/s00101-017-0306-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-017-0306-4

Schlüsselwörter

Keywords

Navigation